Matches in SemOpenAlex for { <https://semopenalex.org/work/W4303946044> ?p ?o ?g. }
- W4303946044 endingPage "5956" @default.
- W4303946044 startingPage "5956" @default.
- W4303946044 abstract "The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus (T2DM) has been associated with decreased skeletal muscle mass but remains unclear in patients with cardiovascular disease (CVD) undergoing comprehensive outpatient cardiac rehabilitation (CR). Therefore, this study investigates the effect of SGLT2 inhibitors on the outcomes of patients with CVD and T2DM undergoing comprehensive outpatient CR. The study included 402 patients with CVD and T2DM who participated in comprehensive outpatient CR. Physical functions (grip strength, maximal quadriceps isometric strength, usual gait speed, and 6-minute walking distance) were measured at discharge as baseline and 5 months thereafter, and the association between physical functions and SGLT2 inhibitor use was reviewed. Physical functions improved regardless of SGLT2 inhibitor use. Multiple regression analysis showed that SGLT2 inhibitor use was not associated with improvement or decline in physical functions (p ≥ 0.05). The use of SGLT2 inhibitors in patients with CVD and T2DM undergoing outpatient CR did not impair improvement in physical functions." @default.
- W4303946044 created "2022-10-10" @default.
- W4303946044 creator A5001598840 @default.
- W4303946044 creator A5007990003 @default.
- W4303946044 creator A5016077468 @default.
- W4303946044 creator A5017948947 @default.
- W4303946044 creator A5022161789 @default.
- W4303946044 creator A5025841183 @default.
- W4303946044 creator A5028261303 @default.
- W4303946044 creator A5050818726 @default.
- W4303946044 creator A5056502497 @default.
- W4303946044 creator A5063616074 @default.
- W4303946044 creator A5067959667 @default.
- W4303946044 creator A5072401293 @default.
- W4303946044 creator A5085914101 @default.
- W4303946044 creator A5087620084 @default.
- W4303946044 date "2022-10-09" @default.
- W4303946044 modified "2023-10-07" @default.
- W4303946044 title "Association between SGLT2 Inhibitors and Cardiac Rehabilitation Outcomes in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus" @default.
- W4303946044 cites W1596389120 @default.
- W4303946044 cites W1915436605 @default.
- W4303946044 cites W2042848793 @default.
- W4303946044 cites W2058552453 @default.
- W4303946044 cites W2114304298 @default.
- W4303946044 cites W2116789370 @default.
- W4303946044 cites W2121960517 @default.
- W4303946044 cites W2130570549 @default.
- W4303946044 cites W2144663588 @default.
- W4303946044 cites W2159296038 @default.
- W4303946044 cites W2164059021 @default.
- W4303946044 cites W2167245776 @default.
- W4303946044 cites W2464760976 @default.
- W4303946044 cites W2591717879 @default.
- W4303946044 cites W2763514410 @default.
- W4303946044 cites W2801524940 @default.
- W4303946044 cites W2886470184 @default.
- W4303946044 cites W2903431537 @default.
- W4303946044 cites W2912344106 @default.
- W4303946044 cites W2913762946 @default.
- W4303946044 cites W2923389432 @default.
- W4303946044 cites W2945855256 @default.
- W4303946044 cites W2976095271 @default.
- W4303946044 cites W2984201386 @default.
- W4303946044 cites W2986499379 @default.
- W4303946044 cites W3013838418 @default.
- W4303946044 cites W3031794754 @default.
- W4303946044 cites W3038803675 @default.
- W4303946044 cites W3093425459 @default.
- W4303946044 cites W3102766101 @default.
- W4303946044 cites W3193297191 @default.
- W4303946044 cites W3193598686 @default.
- W4303946044 cites W3201412557 @default.
- W4303946044 cites W3208762735 @default.
- W4303946044 cites W3210475044 @default.
- W4303946044 cites W3215225781 @default.
- W4303946044 cites W3215582043 @default.
- W4303946044 cites W4205157688 @default.
- W4303946044 cites W4224297974 @default.
- W4303946044 cites W4225396975 @default.
- W4303946044 cites W4226358094 @default.
- W4303946044 cites W4245666729 @default.
- W4303946044 cites W4249976412 @default.
- W4303946044 cites W4281395041 @default.
- W4303946044 cites W4281560562 @default.
- W4303946044 doi "https://doi.org/10.3390/jcm11195956" @default.
- W4303946044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36233823" @default.
- W4303946044 hasPublicationYear "2022" @default.
- W4303946044 type Work @default.
- W4303946044 citedByCount "0" @default.
- W4303946044 crossrefType "journal-article" @default.
- W4303946044 hasAuthorship W4303946044A5001598840 @default.
- W4303946044 hasAuthorship W4303946044A5007990003 @default.
- W4303946044 hasAuthorship W4303946044A5016077468 @default.
- W4303946044 hasAuthorship W4303946044A5017948947 @default.
- W4303946044 hasAuthorship W4303946044A5022161789 @default.
- W4303946044 hasAuthorship W4303946044A5025841183 @default.
- W4303946044 hasAuthorship W4303946044A5028261303 @default.
- W4303946044 hasAuthorship W4303946044A5050818726 @default.
- W4303946044 hasAuthorship W4303946044A5056502497 @default.
- W4303946044 hasAuthorship W4303946044A5063616074 @default.
- W4303946044 hasAuthorship W4303946044A5067959667 @default.
- W4303946044 hasAuthorship W4303946044A5072401293 @default.
- W4303946044 hasAuthorship W4303946044A5085914101 @default.
- W4303946044 hasAuthorship W4303946044A5087620084 @default.
- W4303946044 hasBestOaLocation W43039460441 @default.
- W4303946044 hasConcept C103486182 @default.
- W4303946044 hasConcept C126322002 @default.
- W4303946044 hasConcept C134018914 @default.
- W4303946044 hasConcept C1862650 @default.
- W4303946044 hasConcept C2777180221 @default.
- W4303946044 hasConcept C2777422806 @default.
- W4303946044 hasConcept C2777433710 @default.
- W4303946044 hasConcept C2778818304 @default.
- W4303946044 hasConcept C2779134260 @default.
- W4303946044 hasConcept C2910068830 @default.
- W4303946044 hasConcept C3020110884 @default.
- W4303946044 hasConcept C555293320 @default.
- W4303946044 hasConcept C71924100 @default.